TGFB1 and pulmonary fibrosis: Administration of anti-αvβ6 antibodies was able to attenuate bleomycin-induced pulmonary fibrosis with a concomitant reduction in TGFβ activity (Horan et al. 2008; Patsenker et al. 2009).